Money on the Move: EnPlusOne, Cellarity, Voyager and More
Funding rounds this week saw money flow into innovative drug discovery and delivery platforms, while pharma powerhouse Pfizer wrapped up two high-value neuro deals.
Stay updated with breaking news from Biologically Inspired Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Funding rounds this week saw money flow into innovative drug discovery and delivery platforms, while pharma powerhouse Pfizer wrapped up two high-value neuro deals.
Funding rounds this week saw money flow into innovative drug discovery and delivery platforms, while pharma powerhouse Pfizer wrapped up two high-value neuro deals.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
The company is developing therapeutics for rare genetic diseases affecting the central nervous system, starting with Rett syndrome...
The team added an RNA binding domain into the CRISPR-Cas13a protein to enhance the sensitivity of their COVID-19 assay.